Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase 2 Placebo-Controlled Study of LY2495655 in Patients With Advanced or Metastatic Pancreatic Cancer Receiving Chemotherapy

NCT01505530 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT01505530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01505530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase 2 Placebo-Controlled Study of LY2495655 in Patients With Advanced or Metastatic Pancreatic Cancer Receiving Chemotherapy
Lead sponsor
Eli Lilly and Company
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2011
Completion date
January 31, 2016
Enrollment
125 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer